Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside

Details for Australian Patent Application No. 2008321225 (hide)

Owner Phoenix Biotechnology Inc.

Inventors Yang, Peiying; Newman, Robert A.; Addington, Crandell O.

Agent Watermark

Pub. Number AU-A-2008321225

PCT Pub. Number WO2009/064657

Priority 60/987,501 13.11.07 US

Filing date 6 November 2008

Wipo publication date 22 May 2009

International Classifications

A61K 31/704 (2006.01)

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/064657 Priority application(s): WO2009/064657

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008321245-Wireless communication channel blanking

2008321223-Position sensor for a downhole completion device